[Preliminary study of the relationship between novel coronavirus pneumonia and liver function damage: a multicenter study].
C Liu, Z C Jiang, C X Shao, H G Zhang, H M Yue, Z H Chen, B Y Ma, W Y Liu, H H Huang, J Yang, Y Wang, H Y Liu, D Xu, J T Wang, J Y Yang, H Q Pan, S Q Zou, F J Li, J Q Lei, X Li, Q He, Y Gu, X L Qi
Abstract
The results of this multicenter retrospective study suggests that novel coronavirus pneumonia combined with liver damage is more likely to be caused by adverse drug reactions and systemic inflammation in severe patients receiving medical treatment. Therefore, liver function monitoring and evaluation should be strengthened during the treatment of such patients.
Topics & Concepts
Multicenter studyPneumoniaCoronavirusCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineBetacoronavirusVirologyInternal medicineInfectious disease (medical specialty)DiseaseOutbreakRandomized controlled trialLiver Disease Diagnosis and Treatment